- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06067477
Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups
Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups: a Double-blind, Randomised, Dose-response Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Susan Lanham-New
- Phone Number: 01483686476
- Email: s.lanham-new@surrey.ac.uk
Study Contact Backup
- Name: Abigail Bournot, PhD
- Phone Number: 01483689222
- Email: a.bournot@surrey.ac.uk
Study Locations
-
-
-
Guildford, United Kingdom, GU2 7XH
- Recruiting
- Faculty of Health and Medical Sciences
-
Contact:
- Susan Lanham-New
- Phone Number: 01483686476
- Email: s.lanham-new@surrey.ac.uk
-
Contact:
- Abigail Bournot, PhD
- Phone Number: 01483689222
- Email: a.bournot@surrey.ac.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- British white European, black African/Caribbean, or South Asian (self-reported)
- Living in England for >2 months
- Aged >18 years
- No significant health issues
- English or Urdu speaker
Exclusion Criteria:
- Medical condition or history which might impact study measurements (e.g., ischaemic heart disease, type 1 and type 2 diabetes, thyroid disease, osteoporosis, haematological disease, malignancy)
- Medications known to affect vitamin D metabolism (i.e., hormone replacement therapy, anti-oestrogens treatment, antiepileptic drugs, and breast cancer treatment)
- Pregnant or planning pregnancy during the study period
- Regular use of sun beds
- Having a sun holiday one month prior to commencing study or plans for a sun holiday within the study period. A sun holiday is generally defined as a holiday in a sunny resort outside of the UK. The researchers will assess this on a case-by-case basis depending on the time of year and expected weather conditions
- Reported participation in another clinical trial occurring simultaneously
- Previous intolerance or allergic reaction to vitamin D
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Vitamin D Supplement 400 IU
400 IU (10 µg) of Vitamin D3
|
Vitamin D Supplement
|
Active Comparator: Vitamin D Supplement 1000 IU
1000 IU (25 µg) of Vitamin D3
|
Vitamin D Supplement
|
Active Comparator: Vitamin D Supplement 2000 IU
2000 IU (50 µg) of Vitamin D3
|
Vitamin D Supplement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Concentration of serum 25(OH)D (nmol/L)
Time Frame: Baseline and 12 weeks
|
A blood sample will be analysed using liquid chromatography tandem mass spectroscopy (LC-MS).
Dose-response change in serum 25(OH)D will be measured in nmol/L.
|
Baseline and 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anthropometric measurements - weight (kg)
Time Frame: Baseline and 12 weeks
|
Weight (kg)
|
Baseline and 12 weeks
|
Anthropometric measurements - height (m)
Time Frame: Baseline and 12 weeks
|
Height (m)
|
Baseline and 12 weeks
|
Anthropometric measurements - height (cm)
Time Frame: Baseline and 12 weeks
|
Height (cm)
|
Baseline and 12 weeks
|
Anthropometric measurements - waist circumference (cm)
Time Frame: Baseline and 12 weeks
|
Waist circumference measurement (cm)
|
Baseline and 12 weeks
|
Anthropometric measurements - hip circumference (cm)
Time Frame: Baseline and 12 weeks
|
Hip circumference measurement (cm)
|
Baseline and 12 weeks
|
Concentration of serum calcium (nmol/L)
Time Frame: Baseline and 12 weeks
|
Measure dose-response change in serum calcium measured in nmol/L
|
Baseline and 12 weeks
|
Concentration of plasma parathyroid hormone (PTH) (pg/mL)
Time Frame: Baseline and 12 weeks
|
Measure dose-response change in plasma parathyroid hormone (PTH) measured in pg/mL
|
Baseline and 12 weeks
|
Concentration of serum albumin (g/L)
Time Frame: Baseline and 12 weeks
|
Measure dose-response change in serum albumin measured in g/L
|
Baseline and 12 weeks
|
Concentration of C-Reactive Protein (CRP) (mg/L)
Time Frame: Baseline and 12 weeks
|
Measure dose-response change in CRP measured in mg/L
|
Baseline and 12 weeks
|
Complete blood count
Time Frame: Baseline and 12 weeks
|
Measure change in complete blood count
|
Baseline and 12 weeks
|
Change in immune parameters
Time Frame: Baseline and 12 weeks
|
Measure change in peripheral blood mononuclear cell (PBMC) profile
|
Baseline and 12 weeks
|
Number of participants with Acute Respiratory Tract Infections (ARTIs)
Time Frame: 12 weeks
|
Measure the frequency of ARTIs using a validated questionnaire
|
12 weeks
|
Muscular strength using a handgrip strength test (kg)
Time Frame: Baseline and 12 weeks
|
Muscular strength measured using a dynamometer (measured to the nearest 0.1kg).
The participant will squeeze the dynamometer with maximum effort for 5 seconds.
|
Baseline and 12 weeks
|
Muscular strength and endurance using a sit-to-stand test
Time Frame: Baseline and 12 weeks
|
Number of sit to stands in 30 seconds
|
Baseline and 12 weeks
|
Blood analytes - micronutrient status
Time Frame: Baseline and 12 weeks
|
Measure dose-response change in micronutrient status from blood samples
|
Baseline and 12 weeks
|
Blood analytes - lipid profile (mg/dL)
Time Frame: Baseline and 12 weeks
|
Measure change in lipid profile from blood samples measured in mg/dL
|
Baseline and 12 weeks
|
Vitamin D consumption from diet
Time Frame: Baseline and 12 weeks
|
Vitamin D intake will be measured through a 4-day food diary which participants will fill out for 4 day at home before and after the study.
|
Baseline and 12 weeks
|
Physical activity questionnaire
Time Frame: Baseline
|
Assess level of physical activity using an International Physical Activity Questionnaire (short form)
|
Baseline
|
Sun exposure behaviour questionnaire
Time Frame: Baseline
|
Measures amount of time spent in the sun (often, occasionally, never) and what parts of the body are exposed (head, hands, arms, legs, torso) over summer, spring, autumn and winter.
Also questions any summer holidays abroad, in what month, what country was visited, number of hours of sun per day and what body parts were exposed (head, hands, arms, legs, torso)
|
Baseline
|
UVB sun exposure
Time Frame: Baseline and 12 weeks
|
Sun exposure will be measured by a dosimeter, which measures UVB exposure.
Participants wear this like a badge for 4 days before and after the study.
|
Baseline and 12 weeks
|
Lifestyle questionnaire
Time Frame: Baseline
|
Measures: - Skin type (Fitzpatrick scale) Questions: Questions what ethnicity they identify with, Holidays abroad, Education, Origin, Health, Pregnancy, Sun behaviours (what body parts are usually exposed to the sun, clothing, sun bathing, sunscreen use, sun bed use), Smoking, Drinking, Recreational drug use, Knowledge around vitamin D, supplement use, Milk, egg, oily fish and liver consumption |
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Abigail Bournot, University of Surrey
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FHMS 22-23 194 EGA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin D Deficiency
-
Federal University of Rio Grande do SulCompletedDeficiency, Vitamin DBrazil
-
University Hospital, Clermont-FerrandTerminated
-
Rajavithi HospitalQueen Sirikit National Institute of Child HealthCompleted
-
Universidade de Passo FundoUnknownDeficiency, Vitamin DBrazil
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
Wageningen UniversityDSM Nutritional Products, Inc.; Top Institute Food and NutritionCompletedElderly, Frail | Deficiency, Vitamin DNetherlands
-
University of PaviaIstituti Clinici Scientifici Maugeri SpAUnknownVitamin D Deficiency | Vitamin D3 Deficiency | Vitamin DItaly
-
Okan UniversityArçelik A.Ş.Completed
-
Brigham and Women's HospitalCompletedVitamin d Deficiency
-
Bispebjerg HospitalCompletedObesity | Deficiency, Vitamin D
Clinical Trials on Vitamin D Supplement
-
National and Kapodistrian University of AthensNational Hellenic Research FoundationCompletedOsteopenia | Postmenopausal OsteopeniaGreece
-
Mothaffar RimawiTerminated
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteRecruitingFrailty | Multiple Chronic Conditions | Weakness, MuscleUnited States
-
National Nutrition and Food Technology InstituteCompleted
-
National Taiwan University HospitalCompletedCritical Illness | Vitamin D DeficiencyTaiwan
-
Tirang R. Neyestani, Ph.D.Shahid Beheshti University of Medical SciencesCompletedOverweight | Hypovitaminosis DIran, Islamic Republic of
-
Ege UniversityAvrasya UniversityCompletedCOVID-19 Pandemic | D Vitamin Deficiency | Antibody HypersensitivityTurkey
-
Tirang R. Neyestani, Ph.D.Unknown
-
University of California, San DiegoUniversity of California, Los Angeles; Gilead Sciences; University of Southern... and other collaboratorsCompletedPatient AdherenceUnited States
-
Wake Forest University Health SciencesCompletedNausea | Vitamin D Deficiency | Orthostatic IntoleranceUnited States